CME/CE

Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, women's health and more. And our CME library is continuously growing, every quarter.

3667

LikeLikedUnlike

526-540 of 1027

Real-World Adaptation of Trial Protocols
MinuteCE®
Real-World Adaptation of Trial Protocols
- Roger A. Goldberg, MD, MBA
- Ehsan Rahimy, MD
1.00 program credits
Predicting Durability: Where Are We Now?
MinuteCE®
Predicting Durability: Where Are We Now?
- Justis P. Ehlers, MD, FASRS
- Jennifer, I. Lim, MD, FASRS, FARVO
1.00 program credits
Second-Generation Biomarkers for Treatment Outcomes
MinuteCE®
Second-Generation Biomarkers for Treatment Outcomes
- Justis P. Ehlers, MD, FASRS
- Jennifer, I. Lim, MD, FASRS, FARVO
1.00 program credits
Non-CF Bronchiectasis: How Radiologists Can Drive Better Outcomes
CME/CE
Non-CF Bronchiectasis: How Radiologists Can Drive Better Outcomes
- Robert D. Suh, MD
- Lea Azour, MD
- Ashwin Basavaraj, MD
1.00 credits
Equity in Sight: Addressing Disparities with Advanced Treatment Approaches
CME/CE
Equity in Sight: Addressing Disparities with Advanced Treatment Approaches
- Jennifer, I. Lim, MD, FASRS, FARVO
- Jeremiah Brown Jr., MD, MS, FASRS
- Rahul N. Khurana, MD, FASRS
1.00 credits
Shifting Treatment Paradigm in HFmrEF/HFpEF: Steroidal and Nonsteroidal MRAs
CME/CE
Shifting Treatment Paradigm in HFmrEF/HFpEF: Steroidal and Nonsteroidal MRAs
- Faiez Zannad, MD, PhD
- John McMurray, MD
0.25 credits
advertisement
MinuteCE®
APOC3 Inhibition: New Frontiers Managing Patients with FCS & SHTG
- Daniel Gaudet, MD, PhD
- Børge G. Nordestgaard, MD, DMSc
- Pam R. Taub, MD, FACC, FASPC
- Kausik Ray, MBChB, MD, MPhil
1.00 credits 9 episodes
The Road Ahead: What's on the Horizon for FCS and SHTG Management
MinuteCE®
The Road Ahead: What's on the Horizon for FCS and SHTG Management
- Pam R. Taub, MD, FACC, FASPC
- Prof. Kausik Ray
1.00 program credits
Setting the Bar: Guideline-Recommended Treatment in Hypertriglyceridemia
MinuteCE®
Setting the Bar: Guideline-Recommended Treatment in Hypertriglyceridemia
- Børge G. Nordestgaard, MD, DMSc
- Kausik Ray, MBChB, MD, MPhil
1.00 program credits
FCS: Enhancing the Diagnosis
MinuteCE®
FCS: Enhancing the Diagnosis
- Daniel Gaudet, MD, PhD
1.00 program credits
SHTG: Decoding the Latest Clinical Trial Outcomes
MinuteCE®
SHTG: Decoding the Latest Clinical Trial Outcomes
- Pam R. Taub, MD, FACC, FASPC
- Kausik Ray, MBChB, MD, MPhil
1.00 program credits
Targeting Mixed Hyperlipidemia with APOC3 Inhibition
MinuteCE®
Targeting Mixed Hyperlipidemia with APOC3 Inhibition
- Pam R. Taub, MD, FACC, FASPC
- Kausik Ray, MBChB, MD, MPhil
1.00 program credits
advertisement
Remnant Cholesterol: The Missing Link in ASCVD risk
MinuteCE®
Remnant Cholesterol: The Missing Link in ASCVD risk
- Børge G. Nordestgaard, MD, DMSc
- Kausik Ray, MBChB, MD, MPhil
1.00 program credits
Latest Clinical Trial Outcomes and Breakthroughs for FCS
MinuteCE®
Latest Clinical Trial Outcomes and Breakthroughs for FCS
- Daniel Gaudet, MD, PhD
- Pam R. Taub, MD, FACC, FASPC
1.00 program credits
SHTG: Defining the Unmet Clinical Need
MinuteCE®
SHTG: Defining the Unmet Clinical Need
- Pam R. Taub, MD, FACC, FASPC
- Kausik Ray, MBChB, MD, MPhil
1.00 program credits